Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Intelligent Bio Solutions ( (INBS) ) has shared an announcement.
On January 31, 2025, Intelligent Bio Solutions announced plans to upgrade its Intelligent Fingerprinting Drug Screening System with multilingual capabilities, enhancing accessibility for over 4 billion users globally. This strategic move supports the company’s international expansion and aligns with its 2025 entry into the US market, tapping into the growing demand for workplace drug testing solutions projected to reach $8 billion by 2030.
More about Intelligent Bio Solutions
Intelligent Bio Solutions Inc. is a medical technology company focused on delivering innovative, rapid, and non-invasive testing solutions. Its primary product, the Intelligent Fingerprinting Drug Screening System, uses fingerprint sweat analysis to detect drugs and is aimed at industries requiring safety-critical operations, such as construction and transport.
YTD Price Performance: 12.06%
Average Trading Volume: 128,113
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $7.6M
For detailed information about INBS stock, go to TipRanks’ Stock Analysis page.
